logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Molecular Vaccines From Prophylaxis To Therapy Volume 2 1st Edition Hiroyuki Sasamura Md

  • SKU: BELL-4503058
Molecular Vaccines From Prophylaxis To Therapy Volume 2 1st Edition Hiroyuki Sasamura Md
$ 31.00 $ 45.00 (-31%)

5.0

40 reviews

Molecular Vaccines From Prophylaxis To Therapy Volume 2 1st Edition Hiroyuki Sasamura Md instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 14.72 MB
Pages: 870
Author: Hiroyuki Sasamura MD, PhD, Tasuhiko Azegami MD, PhD, Hiroshi Itoh MD, PhD (auth.), Matthias Giese (eds.)
ISBN: 9783319009773, 9783319009780, 331900977X, 3319009788
Language: English
Year: 2014
Edition: 1

Product desciption

Molecular Vaccines From Prophylaxis To Therapy Volume 2 1st Edition Hiroyuki Sasamura Md by Hiroyuki Sasamura Md, Phd, Tasuhiko Azegami Md, Phd, Hiroshi Itoh Md, Phd (auth.), Matthias Giese (eds.) 9783319009773, 9783319009780, 331900977X, 3319009788 instant download after payment.

This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

Related Products